← All Sponsors
SPONSOR

Tongji University

Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: NSCLC (Advanced Non-small Cell Lung Cancer)
NCT07361237 Phase 1
Recruiting

A Phase l Clinical Study to Evalute the Safety,Tolerability,Pharmacokinetic Characteristics,and Preliminary Anti-tumor Efficacy of HJ-004-02 Tablets in Patients With Non-squamous Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Mutations

NSCLC (Advanced Non-small Cell Lung Cancer)
China View Trial →